Inventor · disambiguated record
Thomas Buser
Also filed as: BUSER THOMAS
18 granted patents·3 pending applications·373 citations·filing 1996–2025
94Inventor score
Top patents by PatentIndex Score
21 records- 0193US11534406B2Delayed release drug formulationTILLOTTS PHARMA AG·Filed 2020·Granted Dec 27, 2022·3 cites·27 claims
- 0293US5792795ATreatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acidsTILLOTTS PHARMA AG·Filed 1996·Granted Aug 11, 1998·155 cites·17 claims
- 0391US5948818ATreatment of inflammatory bowel disease using oral dosage forms of omega-3 polyunsaturated acidsTILLOTTS PHARMA AG·Filed 1998·Granted Sep 7, 1999·140 cites·13 claims
- 0488US10226430B2Delayed release drug formulationTILLOTTS PHARMA AG·Filed 2013·Granted Mar 12, 2019·10 cites·33 claims
- 0587US11517534B2Delayed release drug formulationTILLOTTS PHARMA AG·Filed 2017·Granted Dec 6, 2022·2 cites·31 claims
- 0687US11266605B2Modified release coated capsulesTILLOTTS PHARMA AG·Filed 2015·Granted Mar 8, 2022·3 cites·14 claims
- 0787US9012501B2Type A gelatin capsule containing PUFA in free acid formCHRYSALIS PHARMA AG·Filed 2013·Granted Apr 21, 2015·8 cites·20 claims
- 0887US8383678B2Type a gelatin capsule containing PUFA in free acid formCHRYSALIS PHARMA AG·Filed 2011·Granted Feb 26, 2013·9 cites·20 claims
- 0987US7960370B2Type A gelatin capsule containing PUFA in free acid formSACHETTO JEAN-PIERRE·Filed 2005·Granted Jun 14, 2011·12 cites·10 claims
- 1086US10272048B2Delayed release drug formulationTILLOTTS PHARMA AG·Filed 2016·Granted Apr 30, 2019·4 cites·7 claims
- 1186US9814681B2Delayed release drug formulationTILLOTTS PHARMA AG·Filed 2013·Granted Nov 14, 2017·6 cites·46 claims
- 1286US9364440B2Delayed release drug formulationTILLOTTS PHARMA AG·Filed 2013·Granted Jun 14, 2016·8 cites·50 claims
- 1374US10799515B2Delayed release drug formulationTILLOTTS PHARMA AG·Filed 2013·Granted Oct 13, 2020·1 cites·50 claims
- 1472US9132112B2Type A gelatin capsule containing PUFA in free acid formCHRYSALIS PHARMA AG·Filed 2014·Granted Sep 15, 2015·1 cites·37 claims
- 1567US11998641B2Modified release coated capsulesTILLOTTS PHARMA AG·Filed 2021·Granted Jun 4, 2024·0 cites·10 claims
- 1665US12370147B2Coatable core for a modified release drug formulationTILLOTTS PHARMA AG·Filed 2019·Granted Jul 29, 2025·0 cites·12 claims
- 1760US2025302755A1Coatable core for a modified release drug formulationTILLOTTS PHARMA AG·Filed 2025·Application pending·0 cites
- 1858US2017056354A1Type a gelatin capsule containing pufa in free acid formCHRYSALIS PHARMA AG·Filed 2016·Application pending·0 cites
- 1954US6217897B1Oral mucosal composition comprising 5-aminosalicylic acidTILLOTTS PHARMA AG·Filed 1997·Granted Apr 17, 2001·11 cites·9 claims
- 2053US2015238430A1Pharmaceutical compositionCHRYSALIS PHARMA AG·Filed 2015·Application pending·0 cites
- 2142US11160762B2Modified release coated capsulesTILLOTTS PHARMA AG·Filed 2015·Granted Nov 2, 2021·0 cites·12 claims
Join the waitlist — get patent alerts
Get an alert when Thomas Buser files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →